[go: up one dir, main page]

IL107141A - PHOSPHOLIPID DERIVATIVES CONTAINING HIGHER ELEMENTS OF THE Vth MAIN GROUP, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

PHOSPHOLIPID DERIVATIVES CONTAINING HIGHER ELEMENTS OF THE Vth MAIN GROUP, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
IL107141A
IL107141A IL107141A IL10714193A IL107141A IL 107141 A IL107141 A IL 107141A IL 107141 A IL107141 A IL 107141A IL 10714193 A IL10714193 A IL 10714193A IL 107141 A IL107141 A IL 107141A
Authority
IL
Israel
Prior art keywords
formula
preparation
mmol
diseases
perc
Prior art date
Application number
IL107141A
Other languages
English (en)
Hebrew (he)
Other versions
IL107141A0 (en
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of IL107141A0 publication Critical patent/IL107141A0/xx
Publication of IL107141A publication Critical patent/IL107141A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66Arsenic compounds
    • C07F9/70Organo-arsenic compounds
    • C07F9/72Aliphatic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL107141A 1992-10-01 1993-09-28 PHOSPHOLIPID DERIVATIVES CONTAINING HIGHER ELEMENTS OF THE Vth MAIN GROUP, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IL107141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233044A DE4233044A1 (de) 1992-10-01 1992-10-01 Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten

Publications (2)

Publication Number Publication Date
IL107141A0 IL107141A0 (en) 1993-12-28
IL107141A true IL107141A (en) 1998-01-04

Family

ID=6469408

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107141A IL107141A (en) 1992-10-01 1993-09-28 PHOSPHOLIPID DERIVATIVES CONTAINING HIGHER ELEMENTS OF THE Vth MAIN GROUP, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (23)

Country Link
US (2) US5449798A (xx)
EP (1) EP0594999B1 (xx)
JP (1) JP3688304B2 (xx)
KR (1) KR100331367B1 (xx)
CN (1) CN1055697C (xx)
AT (1) ATE174030T1 (xx)
AU (1) AU661795B2 (xx)
BR (1) BR9303990A (xx)
CA (1) CA2107439C (xx)
DE (2) DE4233044A1 (xx)
DK (1) DK0594999T3 (xx)
EG (1) EG20258A (xx)
ES (1) ES2125935T3 (xx)
FI (1) FI111261B (xx)
GR (1) GR3029423T3 (xx)
HU (1) HU220593B1 (xx)
IL (1) IL107141A (xx)
MX (1) MX9306076A (xx)
NO (1) NO305911B1 (xx)
PH (1) PH29951A (xx)
RU (1) RU2126413C1 (xx)
UA (1) UA39163C2 (xx)
ZA (1) ZA937282B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP026997A0 (en) 1997-11-07 1997-12-04 Resmed Limited Administration of cpap treatment pressure in presence of apnea
WO2004062594A2 (en) * 2003-01-09 2004-07-29 Zeneus Pharma Limited Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
AU2006328479B2 (en) 2005-12-19 2012-03-08 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177216A (en) * 1974-06-21 1979-12-04 The Dow Chemical Company Novel tributyl (2,5-dihydroxyphenyl)phosphonium hydroxide inner salts
US4177716A (en) * 1978-02-21 1979-12-11 Gerald J. Bowe Automatic energy saver and fire damper for exhaust systems
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate

Also Published As

Publication number Publication date
AU661795B2 (en) 1995-08-03
DE4233044A1 (de) 1994-04-07
US5449798A (en) 1995-09-12
CA2107439A1 (en) 1994-04-02
US5637577A (en) 1997-06-10
DK0594999T3 (da) 1999-08-16
JPH06199876A (ja) 1994-07-19
FI934297A0 (fi) 1993-09-30
FI111261B (fi) 2003-06-30
BR9303990A (pt) 1994-06-14
CA2107439C (en) 2006-08-15
HU220593B1 (hu) 2002-03-28
IL107141A0 (en) 1993-12-28
EP0594999B1 (de) 1998-12-02
PH29951A (en) 1996-09-16
ZA937282B (en) 1994-04-25
EP0594999A1 (de) 1994-05-04
UA39163C2 (uk) 2001-06-15
JP3688304B2 (ja) 2005-08-24
MX9306076A (es) 1994-05-31
KR100331367B1 (ko) 2002-11-13
RU2126413C1 (ru) 1999-02-20
HUT65681A (en) 1994-07-28
AU4874793A (en) 1994-04-14
NO933505L (no) 1994-04-05
NO305911B1 (no) 1999-08-16
GR3029423T3 (en) 1999-05-28
ES2125935T3 (es) 1999-03-16
EG20258A (en) 1998-05-31
HU9302772D0 (en) 1993-12-28
DE59309182D1 (de) 1999-01-14
FI934297L (fi) 1994-04-02
NO933505D0 (no) 1993-09-30
CN1088583A (zh) 1994-06-29
KR940009201A (ko) 1994-05-20
CN1055697C (zh) 2000-08-23
ATE174030T1 (de) 1998-12-15

Similar Documents

Publication Publication Date Title
EP0050327B1 (de) Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69704286T2 (de) Phosphonat-Nukleotid-Verbindungen
CZ541288A3 (cs) 4' -fosfátu epipodofyllotoxinglukosidů, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
EP0108565A2 (en) Phospholipids, their production and use thereof
AU2004285831B2 (en) Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
EP0070433A1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same
US20090082569A1 (en) Narcistatin prodrugs
EP0061872A1 (en) Ethyleneglycol derivatives, their production and use
JP3009196B2 (ja) 抗ウイルス活性を有する薬剤、燐脂質誘導体及びその製造方法
EP0027597B1 (en) Mono(2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r-cis)-(3-methyloxiranyl)phosphonate, its preparation and pharmaceutical compositions containing it
IL107141A (en) PHOSPHOLIPID DERIVATIVES CONTAINING HIGHER ELEMENTS OF THE Vth MAIN GROUP, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IE48781B1 (en) Fosfomycin derivatives
US6172050B1 (en) Phospholipid derivatives
CA2511753C (en) Phospholipid derivatives
EP0521353B1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
US5958906A (en) Phospholipid derivatives containing higher elements of the fifth main group
JPH0617307B2 (ja) 抗腫瘍剤
AT393505B (de) Arzneimittel, welche alkylphosphoamine in kombination mit einem alkylglycerin enthalten
AU602537B2 (en) Acylation products of bis(2-imidazolin-2-ylhydrazones) of 9,10-anthracenedicarboxaldehyde
JPH029594B2 (xx)
FI65261B (fi) Foerfarande foer framstaellning av farmakologiskt anvaendbart dinatriumsalt av n-(fosfonoacetyl)-l-asparaginsyra
IL30918A (en) Process for preparing the history of the acid cis-1,2-apoxypropyl-phosphonic
EP0248858B1 (de) Neue phosphorverbindungen und diese enthaltende arzneimittel
JPS6257191B2 (xx)
DE4133080A1 (de) Plasmalogenanaloga

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees